A monoclonal antibody raised against the Mauthner cell also recognizes some reticular neurons

A Triller1, M A Nicola, E Coudrier

  • 1Neurobiologie Cellulaire (INSERM U261), Institut Pasteur, Paris, France.

Neuroscience
|January 1, 1991
PubMed

Insights

A new antibody (mAb 222C2) specifically targets Mauthner cells in goldfish, revealing a unique protein marker. This discovery aids in understanding neuronal development and relationships within the goldfish brain.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Mauthner cells are crucial for goldfish escape responses.
  • Understanding neuronal markers is key to studying brain development and function.

Purpose of the Study:

  • To develop a monoclonal antibody targeting Mauthner cells in goldfish.
  • To characterize the localization and distribution of the recognized antigenic determinant.

Main Methods:

  • Hybridoma technology was used to generate monoclonal antibodies.
  • Immunohistochemistry and electron microscopy were employed for cellular localization.
  • The antibody (mAb 222C2) was tested on goldfish brain tissue.

Main Results:

  • mAb 222C2 specifically recognized a determinant on Mauthner cell soma and dendrites.
  • The antigen was localized to polyribosomes and reticulum near Golgi cisternae.
  • Other large neurons in reticular nuclei were also labeled, suggesting potential functional or developmental links.

Conclusions:

  • The antibody mAb 222C2 serves as a valuable marker for Mauthner cells and related neurons.
  • The findings suggest a functional or developmental relationship between Mauthner and reticular cells.
  • Further studies can utilize this antibody for developmental research on these neuronal populations.

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...